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Abstract 
The chicken B-cell line DT40 has two isoforms of phosphatidylinositol 5-phosphate 
4-kinase (PI5P4K), α and β, likely to exist as a mix of obligate homo- and hetero-
dimers. Previous work has led us to speculate that an important role of the β isoform 
may be to target the more active PI5P4Kα isoform to the nucleus. Here we expand 
upon that work by genomically tagging the PI5P4Ks with fluorochromes in the 
presence or absence of stable or acute depletions of PI5P4Kβ. Consistent with our 
original hypothesis we find that PI5P4Kα is predominantly (possible entirely) 
cytoplasmic when PI5P4Kβ is stably deleted from cells. In contrast, when PI5P4Kβ is 
inducibly removed within an hour PI5P4Kα retains its wild type distribution of 
approximately 50:50 between cytoplasm and nucleus even through a number of cell 
divisions. This leads us to speculate that PI5P4Kα is chromatin associated. We also 
find that when cells are in the exponential phase of growth PI5P4Kβ is primarily 
cytoplasmic but translocates to the nucleus upon growth into the stationary phase or 
upon serum starvation. Once again this is not accompanied by a change in PI5P4Kα 
localization and we show, using an in vitro model, that this is possible because the 
dimerization between the two isoforms is dynamic. Given this shift in PI5P4Kβ upon 
nutrient deprivation we explore the phenotype of PI5P4Kβ null cells exposed to this 
stress and find that they can sustain a greater degree of nutrient deprivation than their 
wild type counterparts possibly as a result of upregulation of autophagy. 
 
Summary Statement 
It is presently believed that the phosphatidylinositol 5-phosphate 4-kinases are 
obligate dimers. Here we show that the isoforms can in fact be independently 
regulated which may account for the particular role of the beta isoform in stress 
responses including autophagy. 
 
Short Title 
Independent regulation of the phosphatidylinositol 5-phosphate 4-kinases. 
 
Keywords 
Phosphatidylinositol 5-phosphate 4-kinase; phosphatidylinositol 5-phosphate; 
starvation; autophagy; cell cycle. 
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Abbreviations 
DNA  Deoxyribonucleic acid 
EmGFP Enhanced monomeric green fluorescent protein 
FBS  Foetal bovine serum 
PAGE  Polyacrylamide gel electrophoresis 
PCR  Polymerase chain reaction 
PI5P4K Phosphatidylinositol 5-phosphate 4-kinase 
PIP  Phosphatidylinositol phosphate 
SDS  Sodium dodecyl sulphate 
 
Introduction  
The phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) are a family of three 
(PI5P4Ks α, β and γ), whose cellular functions are still poorly understood (for reviews 
see [1-3]). Their principal activity is believed to be to remove, and thus regulate the 
levels of, their substrate PI5P, which is present in cells at slightly lower levels than 
PI3P and much lower levels than PI4P [1, 4]. PI5P has been reported to be present in 
the plasma membrane [4, 5], intracellular membranes [5] and the nucleus [6], and 
several studies suggest effectors and functions for this lipid in the nucleus [2, 7-9] and 
the cytoplasm [10].  
 
The localization of the PI5P4Ks is clearly central to understanding their functions and 
those of PI5P, yet the literature has been confusing on this critical issue. Using 
immunolocalization of endogenous proteins, Boronenkov et al [11] reported that both 
PI5P4Kα and PI5P4Kβ were present in the nucleus, while transfection studies 
suggested that PI5P4Kα is primarily cytoplasmic and PI5P4Kβ is mostly nuclear with 
its localization being dictated by an unusual nuclear localization sequence, an α-helix 
[12] numbered α-7 in the structure of PI5P4Kβ [13]. However, using highly isoform-
specific antibodies, Bultsma et al [14] reported that both PI5P4Kα and PI5P4Kβ were 
in the nucleus and cytoplasm, while using genomic tagging of PI5P4Ks in DT40 cells 
Richardson et al [15] and Wang et al [16] reported that PI5P4Kβ was almost entirely 
nuclear while PI5P4Kα was 40% nuclear and 60% cytoplasmic.  
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A complicating factor in understanding these issues has been the discovery that 
PI5P4Kα and PI5P4Kβ heterodimerize [14, 16] as might be expected given that their 
dimerization sequences [13] are near identical between the isoforms. Indeed Bultsma 
et al showed that PI5P4Kα and PI5P4Kβ are likely to exist as a mix of obligate homo 
and heterodimers in vivo [14]. DT40 cells, being of avian origin, lack a PI5P4Kγ 
isoform [16, 17], but we have shown that PI5P4Ks α and γ can also heterodimerize at 
least in vitro [17], so there is no reason to suppose that PI5P4Kβ and PI5P4Kγ will 
not heterodimerize too. So two key questions concerning PI5P4K and PI5P functions 
in the nucleus are: is PI5P4Kβ cytoplasmic [14] because it is pulled out of the nucleus 
by one or both of the other isoforms, and is a primary role of PI5P4Kβ to target the 
much more enzymatically active PI5P4Kα [14, 16] to the nucleus [16]?  
 
To resolve these issues we have further employed the remarkable genetic power of 
DT40 cells to tag both the endogenous PI5P4Ks with EmGFP, to delete both alleles of 
PI5P4Kβ, and to tag both alleles of PI5P4Kβ with the auxin degron [18] so that we 
can remove it from the cells within minutes. In all cases we can follow the 
localization of the endogenous proteins by cell fractionation or confocal imaging, and 
by these strategies we have gained significant insight into the dynamic relationship 
between these two proteins. 
 
Materials and Methods 
DT40 tissue culture 
Basic culture medium for DT40 cells was formulated according to the protocol of 
[23]. To 500ml of RPMI medium was added 50ml of FBS, 
5ml of 200mM L-glutamine, 5ml of chicken serum, and 120μl of 50mM 2- 
mercaptoethanol. Cells were cultured at 41°C in 5% carbon dioxide. 
 
Generation of targeting constructs for targeted transfection of DT40 cells 
Targeting constructs were built into an appropriate plasmid vector (typically 
pBluescript SK+ (Stratagene)). For gene deletions sequences of genomic DNA 
flanking the region to be deleted (targeting arms) were PCR amplified from DT40 
genomic DNA and ligated into the plasmid vector separated by an antibiotic 
resistance cassette to allow selection of drug-resistant clones. The targeting arms were 
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typically 2kb in length. Following successful transfection and integration into the 
germline by homologous recombination the antibiotic resistance cassette replaced the 
region of the gene targeted for deletion. For integration of tags into the 
germline a similar strategy was employed, but in this case the targeting arms were 
manipulated such that successful recombination led to introduction of the new 
sequence of choice. See supplementary methods for further details. 
 
Targeted transfection of DT40 cells 
Targeting constructs were linearized using an appropriate restriction enzyme, 
recovered by lithium chloride precipitation, and transfected into DT40 cells in the 
logarithmic phase of growth by electroporation (600V, 25μF, exponential pulse, 
Biorad Gene Pulser XCell). The cells were then immediately seeded out 
in 96 well plates and 24 hours later the appropriate selection antibiotic(s) was added. 
Colonies resulting from single cells were picked and subjected to sequencing in order 
to verify correct construct integration. All results were verified in multiple 
independently derived clones. 
 
Fractionation of nuclear and cytoplasmic proteins in DT40 cells 
This was performed essentially as set out in [23]. 1x107 cells were harvested by 
centrifugation at 300g for 5 mins and washed twice in PBS before being resuspended 
in 1ml of suspension buffer (0.32M sucrose and protease inhibitor cocktail in PBS). 
10µl of 10% (v/v) IGEPAL CA-630 in PBS was added to the cell suspension with 
mixing by gentle pipetting to give a final detergent concentration of 0.1%. The 
suspension was immediately centrifuged at 5500rpm for 30 secs at 4°C in a 
microcentrifuge to pellet the nuclei. The supernatant was aspirated and kept as the 
cytoplasmic protein fraction. The nuclei were resuspended in 1ml of suspension 
buffer to wash them. Prior to centrifugation at 1500rpm for 5 mins at 4°C an aliquot 
was examined by light microscopy to check that the nuclei were clean. The nuclear 
pellet was next resuspended in 1ml of nuclear extraction buffer (20mM HEPES pH 
7.7, 1.5mM magnesium chloride, 0.42M sodium chloride, and protease inhibitor 
cocktail in water) and incubated on ice for 20 minutes. This suspension was then 
centrifuged at 9400rpm for 15 mins at 4°C in a microcentrifuge and the supernatant 
aspirated as the nuclear protein fraction. In all fractionation experiments the protein 
species being examined was immunoprecipitated from the fractions before being 
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blotted. We always used an excess of immunoprecipitating antibody and so all the 
protein we could recover from the fractions is loaded onto the gel. 
 
Immunoprecipitation of proteins from DT40 cells 
The antibody for immunoprecipitation was conjugated to protein G sepharose beads 
which were then used to immunoprecipitate the target protein from cell free extract. 
An excess of antibody over antigen was used as determined empirically. Antigen was 
eluted from the beads by boiling in SDS loading buffer in preparation for denaturing 
polyacrylamide gel electrophoresis. 
 
Western blotting 
Following denaturing SDS-PAGE electrophoresis proteins were transferred onto an 
appropriate blotting membrane, which was probed with antibodies as detailed in the 
supplementary methods and detected using chemiluminescent reagent of an 
appropriate sensitivity. 
 
Confocal Microscopy 
Images were acquired with a Leica SP5 confocal microscope attached to a Leica 
DMI6000 inverted microscope stand. For GFP imaging excitation was with the 
488nm line of the argon laser and emission was detected between 500 and 550nm. For 
all imaging the confocal pinhole was set to 1 Airy unit, and an oil immersion 40x 1.25 
NA objective lens was used. All imaging was performed on live cells, which were 
embedded in Matrigel to prevent cell movement and transferred to uncoated glass 
bottom MatTek dishes. Just prior to imaging full growth medium was removed and 
replaced with RPMI without phenol red. Imaging was performed at 41°C under 5% 
CO2. 
 
Dimerization assays 
Untagged recombinant PI5P4Kγ was allowed to reach equilibrium at a concentration 
where dimers were the predominant form [17] and then diluted to a concentration 
where we would expect dissociation into monomers [17]. Samples of this solution 
were then taken every 5 to 15 minutes to monitor the kinetics of dimer dissociation. 
These samples were cross-linked within 1 second (not shown) with a 50 fold molar 
excess of BS3 [bis(sulfosuccinimidyl)suberate] and the reaction was quenched with 
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50mM Tris/HCl, pH 7.4. The mixture of dimers and monomers present was assayed 
by denaturing SDS-PAGE followed by western blotting with an anti-PI5P4Kγ 
antibody (see supplementary methods). 
 
Cell cycle analysis by flow cytometry 
1x107 cells were fixed in ethanol then stained with 25 micrograms/ml propidium 
iodide containing RNaseA at 250 micrograms/ml. Cells were analysed using a BD 
FACScan, exciting with the 488nm line of the argon laser and collecting through the 
650nm long-pass filter. Dead cells were excluded as were cellular doublets and higher 
order clumps. At least 1x105 events were collected for each sample. 
 
Results and Discussion 
PI5P4Kα is almost exclusively cytoplasmic upon genetic deletion of PIP4K2B 
If our speculation based upon previous data [16] is correct that PI5P4Kα requires 
targeting by PI5P4Kβ to enter the nucleus then we reasoned that PI5P4Kα should be 
exclusively cytoplasmic in PIP4K2B null cells. We therefore created a cell line in 
which both alleles of PIP4K2B were deleted and one allele of PIP4K2A was 
endogenously tagged at the C-terminus with the coding sequence for EmGFP 
(PIP4K2AEmGFP/wt/wt PIP4K2B-/- cells). Note that karyotype analysis shows DT40 cells 
exhibit trisomy for chromosome 2, the chromosome on which the PIP4K2A gene is 
located (not shown). PIP4K2AEmGFP/wt/wt cells (with wild type PIP4K2B) acted as a 
control. As anticipated [16] PI5P4Kα is distributed approximately equally between 
cytoplasm and nucleus in a wild type PIP4K2B background whilst deletion of 
PIP4K2B results in a marked shift of PI5P4Kα out of the nucleus (figure 1A and B). 
It is impossible to know whether the small amount of PI5P4Kα that persists in the 
nuclear fraction in PIP4K2B null cells is truly nuclear or whether this represents an 
artifact of an inevitably less than perfect separation of nucleus from cytoplasm. 
Certainly no nuclear PI5P4Kα-EmGFP is visible in the nuclei of these cells upon 
confocal microscopy (not shown) although this is a less sensitive technique than 
immunoprecipitation and western blotting and so does not really help to answer the 
question. Whatever the truth of the matter it is certainly accurate to say that genomic 
deletion of PIP4K2B results in PI5P4Kα distributing away from the nucleus largely, 
possibly entirely. It is, of course, important to know that endogenous tagging does not 
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affect protein function, and we address this further under supplementary results and 
discussion. 
 
Acute depletion of PI5P4Kβ does not result in any redistribution of PI5P4Kα 
In light of these findings we thought it would be interesting to study the kinetics of 
redistribution of PI5P4Kα away from the nucleus upon acute removal of PI5P4Kβ. 
We therefore created a cell line in which PI5P4Kβ was endogenously tagged (at both 
alleles) with the auxin degron system [18] in order to enable the localization of 
PI5P4Kα endogenously tagged with EmGFP to be studied upon rapid depletion of 
PI5P4Kβ by addition of auxin. Note that we placed a (His)6-FLAG tag in frame with 
the degron tag on the PIP4K2B alleles to allow for easy immunoprecipitation and 
blotting of the fusion protein. The resultant cell line is 
PIP4K2AEmGFP/wt/wtPIP4K2Bdegron/degron. To our surprise removal of PI5P4Kβ, which 
as far as we can tell from immunoprecipitation and western blotting is (virtually) 
complete (figure 2A), has no effect on the localization of PI5P4Kα which remains 
approximately equally distributed between the cytoplasm and nucleus (figure 2B). 
This persists even after 16 hours of PI5P4Kβ depletion by which time these rapidly 
proliferating cells have gone through two or three rounds of division with breakdown 
and re-formation of the nuclear envelope. This makes unlikely the explanation that 
PI5P4Kα has simply been ‘ferried’ to the nucleus by PI5P4Kβ where it becomes 
trapped by the nuclear envelope, but coupled with the requirement PI5P4Kα has for 
PI5P4Kβ to enter the nucleus in the long-term (figure 1A,B) it is possible that nuclear 
PI5P4Kα is chromatin associated. Unfortunately problems with auxin toxicity after 
about 24 hours mean we are unable to continue PI5P4Kβ depletion for long enough to 
observe the ‘acute’ phenotype transform into the ‘chronic’ phenotype. 
 
In these cells we also took the opportunity to study the distribution of degron tagged 
PI5P4Kβ between cytoplasm and nucleus. To our surprise PI5P4Kβ was 
predominantly (about 90%) cytoplasmic (figure 2B). This is in complete contradiction 
to our previous data where PI5P4Kβ endogenously tagged with (His)6-FLAG was 
found to be 90% nuclear [16]. In order to confirm this finding and convince ourselves 
that everything we found with the degron system was not artefactual, we decided to 
re-explore the entire issue of the localization of PI5P4Kα and PI5P4Kβ using 
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endogenous EmGFP tags in an otherwise wild-type background, particularly as we 
have data elsewhere (Bulley, Droubi et al., unpublished) demonstrating that 
endogenous EmGFP tags do not affect the in vivo function, and therefore presumably 
localization, of the PI5P4Ks. Note that we have already presented data from 
PIP4K2AEmGFP/wt/wt cells (figure 1A) but we decided to go on to tag a second 
PIP4K2A allele with EmGFP in order to enhance the signal for confocal microscopy. 
 
Localization of EmGFP-tagged PI5P4Kα and PI5P4Kβ 
Once again we used the high homologous recombination frequency of the DT40 line 
to knock EmGFP tags into two PIP4K2A alleles and both PIP4K2B alleles in separate 
cells lines to create PIP4K2AEmGFP/EmGFP/wt and PIP4K2BEmGFP/EmGFP cells 
respectively. We looked at the localization of the tagged proteins by both confocal 
microscopy and cell fractionation. As expected PI5P4Kα has an approximately equal 
cytoplasmic / nuclear localization (figure 3A,B) (cytoplasm to nuclear ratio 1.2, 95% 
CI 1.1 to 1.3, n=3), which is consistent with what we have seen throughout this 
current study, and consistent with what we have reported before in these cells [16] 
and what others have reported for the endogenous protein in mammalian cells [11, 
14]. 
 
PI5P4Kβ, in contrast, is almost entirely cytoplasmic (figure 3A,B) (cytoplasm to 
nuclear ratio 11.5, 95% CI 8.2 to 14.7, n=3). Whilst this is consistent with what we 
saw with degron-tagged PI5P4Kβ (above) it is completely inconsistent with what we 
previously reported in DT40s [15, 16] where we found PI5P4Kβ to be almost 
exclusively nuclear upon both overexpression and endogenous tagging, and indeed 
inconsistent with most reports on other cells [11, 14]. We wondered if this 
inconsistency was a result of the different growth state of the cells, as in the present 
experiments we were careful to assay the cells in the exponential phase of growth, 
whereas in our earlier experiments [16] we had grown the cells into or close to the 
stationary phase in order to get the maximum yield of protein for downstream 
applications. We therefore let the cells grow on into the stationary phase and an 
almost complete shift in PI5P4Kβ towards the nuclear compartment was revealed 
(figure 4A), making the present results consistent with our earlier study [16] as long 
as the cells are sampled under the correct experimental conditions. Live cell confocal 
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microscopy reveals that translocation of PI5P4Kβ to the nucleus upon growth into the 
stationary phase occurs in some cells before others (figure 4C left panel). We 
confirmed this result in the cells we have already described (figure 2) in which 
PI5P4Kβ is tagged at both alleles with the auxin degron and (His)6-FLAG (figure 
4B). Once again acute removal of PI5P4Kβ by addition of auxin resulted in no change 
in the subcellular localization of PI5P4Kα (figure 4B). To investigate what the major 
factor might be in causing this change we transferred PIP4K2BEmGFP/EmGFP cells in the 
logarithmic phase of growth to a medium with no soluble nutrients (amino acids etc), 
or to one with no added serum. The former caused no change (not shown), but in cells 
deprived of serum a translocation of PI5P4Kβ to the nucleus occurred within an hour 
(figure 4D). Finally, we repeated these experiments with PIP4K2AEmGFP/EmGFP/wt cells, 
and saw no significant change in PI5P4Kα localization, either growing the cells into 
the stationary phase (not shown) or depriving them of serum (figure 4D).  
 
Kinetics of dimer dissociation 
In the context of seemingly independent behaviour of PI5P4Kα and PI5P4Kβ under 
conditions of serum deprivation and acute depletion of PI5P4Kβ it is relevant to 
remember that the two PI5P4K isoforms are extensively heterodimerizing in DT40 
cells [16]. So the independent movement of PI5P4Kβ into the nucleus while PI5P4Kα 
remains apparently unmoved (figure 4D), plus the unchanged location of PI5P4Kα 
while PI5P4Kβ is removed, both suggest that the two PI5P4Ks are in quite a rapid 
equilibrium; these observations would be inconsistent with a stable 
heterodimerization where once bound to each other the two remained so over a long 
time course. However, we currently have no idea at all what the likely timescale of 
their binding to each other is. But we can address this question indirectly by exploring 
the dissociation of PI5P4Kγ homodimers.  
 
We used this surrogate strategy for three reasons: Firstly, because it is essential that 
we should use untagged protein (tags might enhance or hinder the interaction) and we 
do not have the necessary isoform-specific antibodies for PI5P4Kα and PI5P4Kβ, 
whereas we do have an anti-PI5P4Kγ antibody [19]; secondly, creating and isolating a 
pure PI5P4Kα/PI5P4Kβ heterodimer population to investigate dissociation would be 
extremely difficult; and thirdly, the hydrogen bonding between PI5P4Kγ homodimers 
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is almost exactly the same as PI5P4Kα/PI5P4Kβ heterodimers [17], so PI5P4Kγ 
homodimers are a suitable model to investigate this question. 
  
Figure 5 shows a typical experiment where we incubated recombinant PI5P4Kγ at a 
concentration at which it is dimeric [17], and then diluted rapidly to a concentration at 
which it is entirely monomers [17], taking samples every 5-15 minutes and adding a 
cross-linker at a concentration that stabilized the dimers within 1 second (not shown). 
Because our antibody does not immunoprecipitate we could not easily concentrate the 
diluted enzyme before gel electrophoresis and western blotting, so detection and 
quantification of the extremely dilute protein preparations pushes the sensitivity of 
western blotting to the extreme. But it is nevertheless clear even from this semi-
quantitative experiment (figure 5) that the dissociation of the PI5P4Kγ dimers is 
detectable within a few minutes with an approximate half life of 10-15 mins. This 
short time frame is consistent with the independent behaviour of PI5P4Ks α and β in 
the contexts discussed above. 
 
PIP4K2B-/- cells are able to sustain high levels of nutrient deprivation 
Given the nuclear translocation of PI5P4Kβ upon proliferation of cells into the 
stationary phase we wondered whether the growth characteristics of PIP4K2B 
knockout cells would differ from those of their wild type counterparts. As a control 
we generated PIP4K2A null cells (PIP4K2A-/-/-). Consistent with the subcellular 
localization data the growth characteristics of PIP4K2A-/-/- cells are unchanged 
compared to wild type (data not shown) but PIP4K2B-/- cells remain in the 
exponential phase of growth for longer than their wild type controls. This results in 
PIP4K2B-/- cells attaining a higher cell density in the plateau phase than wild type 
DT40 cells (figure 6A). This difference in growth characteristics is interesting, 
particularly since the type 1 and type 2 PIP kinases can interact [20], and the type 1 
PtdInsP kinases in turn interact with the G1/S checkpoint protein retinoblastoma [21]. 
We therefore wondered whether loss of PIP4K2B resulted in dysregulation of the 
G1/S checkpoint. Cell cycle analysis by flow cytometry shows that PIP4K2B-/- cells 
continue to proliferate for longer than wild type (which we knew anyway from the 
growth curves) but following this extended period of growth they do enforce the G1/S 
checkpoint appropriately (figure 6B). 
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Autophagy is upregulated in PIP4K2B-/- cells 
Given that the outgrowth of PIP4K2B-/- cells does not seem to be due to breakdown 
of the G1/S checkpoint we wondered whether autophagy, a mechanism for promoting 
cellular survival during periods of starvation [22], might be affected. We therefore 
assayed autophagy by blotting against the autophagy marker LC3-II, and found that 
autophagy is enhanced in PIP4K2B-/- cells (figure 7A) but not in PIP4K2A-/-/- cells 
(not shown). The best characterized regulator of autophagy is mTORC1, which acts 
as a negative regulator [22]. We therefore hypothesized that mTORC1 would be less 
active in PIP4K2B-/- cells (but not in PIP4K2A-/-/- cells) and indeed find this to be the 
case by blotting for phosphorylation of the mTORC1 target p70S6K (figure 7B). We 
have data elsewhere (Bulley, Droubi et al., in submission) showing that loss of 
PI5P4Kβ does not affect Akt phosphorylation and so the influence of PI5P4Kβ does 
not appear to extend to mTORC2 targets. It may therefore be that PI5P4Kβ regulates 
autophagy via a direct or indirect impact upon mTORC1 activity. It was recently 
suggested that knockdown of any of the three mammalian isoforms of PI5P4K can 
induce autophagy due to build up of their substrate PI5P which in turn recruits 
autophagy effectors normally held to be dependent upon PI3P [24]. Our data is not 
entirely consistent with this but investigation of the mechanism linking PI5P4Kβ to 
autophagy may be an interesting and fruitful avenue for future work. 
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Figure Legends 
Figure 1 
Effect of deletion of PIP4K2B on the cellular localization of PI5P4Kα. The PI5P4Kα-
EmGFP fusion protein was detected by immunoprecipitation and blotting against the 
EmGFP tag. 107 cells were fractionated into cytoplasmic and nuclear fractions and the 
EmGFP fusion protein was recovered from the fractions with an excess of 
immunoprecipitating antibody. 
A: Distribution of PI5P4Kα between cytoplasm and nucleus in cells with either wild 
type or deleted PIP4K2B. β-actin and histone H3 blots are shown as fractionation 
markers. Immunoprecipitation with Invitrogen A-6455 anti-GFP and blots with 
Invitrogen 33-2600 anti-GFP, Sigma AC74 anti-beta actin, and Abcam ab1791 anti-
histone H3. 
B: Quantification of three such blots by densitometry. Bars shows mean and 95% 
confidence interval. 
 
Figure 2 
Effect of acute removal of PI5P4Kβ on the cellular localization of PI5P4Kα. The 
PI5P4Kβ-degron fusion protein was detected by immunoprecipitation against the 
FLAG epitope and blotting against the poly-His tag. PI5P4Kα was detected as 
described for figure 1. Auxin was used at a concentration of 500 micromolar. 
A: Treatment of PIP4K2Bdegron/degron cells with auxin for 30 minutes renders PI5P4Kβ 
undetectable. Immunoprecipitation with Sigma A2220 anti-FLAG and blot with 
Abcam ab9108 anti-hexaHis. 
B: Distribution of PI5P4Kα and PI5P4Kβ between cytoplasm and nulceus with no 
auxin treatment, or auxin treatment for 4 or 16 hours. We do not know the identity of 
the non-specific band in the cytoplasmic fractions. Cytoplasmic and nuclear fractions 
were assessed as adequately pure (data not shown) in the same way as in figure 1. 107 
cells were fractionated into cytoplasmic and nuclear fractions and the fusion protein 
was recovered from the fractions with an excess of immunoprecipitating antibody. 
Immunoprecipitation with Invitrogen A-6455 anti-GFP or Sigma A2220 anti-FLAG 
and blots with Invitrogen 33-2600 anti-GFP or Abcam ab9108 anti-hexaHis. 
Representative blot from three biological replicates. 
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Figure 3 
Cellular localization of PI5P4Kα and PI5P4Kβ with genomic EmGFP tags in DT40 
cells. The fusion proteins were detected as described for figure 1. 
A: Distribution of the PI5P4Ks between cytoplasm and nucleus in cells in the 
logarithmic phase of growth. Cytoplasmic and nuclear fractions were assessed as 
adequately pure (data not shown) in the same way as in figure 1. 107 cells were 
fractionated into cytoplasmic and nuclear fractions and the EmGFP fusion protein was 
recovered from the fractions with an excess of immunoprecipitating antibody. 
Immunoprecipitation with Invitrogen A-6455 anti-GFP and blot with Invitrogen 33-
2600 anti-GFP. 
B: Live cell confocal images of the same cell lines. 
 
Figure 4 
Nuclear translocation of PI5P4Kβ upon cell growth into the stationary phase or serum 
starvation. The EmGFP and degron containing fusion proteins were detected as 
described for figures 1 and 2 respectively. Cytoplasmic and nuclear fractions were 
assessed as adequately pure (data not shown) in the same way as in figure 1. 107 cells 
were fractionated into cytoplasmic and nuclear fractions and the fusion protein was 
recovered from the fractions with an excess of immunoprecipitating antibody. 
A: Distribution of PI5P4Kβ between cytoplasm and nucleus as cells move from the 
logarithmic to stationary phase of growth. Immunoprecipitation with Invitrogen A-
6455 anti-GFP and blot with Invitrogen 33-2600 anti-GFP. Representative blot from 
three biological replicates. 
B: Distribution of the PI5P4Kβ-degron fusion protein between cytoplasm and nucleus 
when cells are in the stationary phase of growth, and the effect of auxin treatment 
upon PI5P4Kα localization. Top blot shows the PI5P4Kβ-degron fusion protein. 
Bottom blot shows the PI5P4Kα-EmGFP fusion protein. Auxin was used at a 
concentration of 500 micromolar. Immunoprecipitation with Invitrogen A-6455 anti-
GFP or Sigma A2220 anti-FLAG and blots with Invitrogen 33-2600 anti-GFP or 
Abcam Ab9108 anti-hexaHis. Representative blot from three biological replicates. 
C: Live cell confocal images of PIP4K2BEmGFP/EmGFP cells as they enter the stationary 
phase of growth. Scale bars represent 10 micrometres. 
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D: Distribution of PI5P4Kα and PI5P4Kβ between cytoplasm and nucleus when cells 
are serum replete in the logarithmic phase of growth, and when they are switched to 
serum free medium for 1 hour whilst in the logarithmic phase of growth. 
Immunoprecipitation with Invitrogen A-6455 anti-GFP and blot with Invitrogen 33-
2600 anti-GFP. Representative blot from three biological replicates. 
 
Figure 5 
Kinetics of dissociation of PI5P4Kγ dimers. 
Untagged recombinant PI5P4Kγ was allowed to reach equilibrium at a concentration 
where dimers are the predominant species. The solution was then diluted to a 
concentration at which we would expect monomers to predominate and samples were 
taken with cross linking at the intervals shown. Detection with anti-PI5P4Kγ antibody 
[17] as specified in supplementary methods. Representative blot from three replicates. 
 
Figure 6 
Growth characteristics of PIP4K2B-/- cells. 
A: WT DT40 and PIP4K2B-/- cells were allowed to grow into the death phase without 
replacement of growth medium. Although the rate of proliferation of the two cell lines 
is similar in the exponential phase, this phase lasts longer in PIP4K2B-/- cells resulting 
in these cells attaining a higher density in the stationary phase. Cell density was 
significantly higher for PIP4K2B-/- cells at all time points from 30 hours onwards, 
P<0.001. Data analysis by ANOVA. At each data point mean and 95% confidence 
interval is plotted. n=3 biological replicates. 
B: Representative flow cytometry traces of cell cycle distribution corresponding to the 
growth curves in (A). Graph shows the percentage of cells in G1 at each time point. 
WT DT40 and PIP4K2B-/- cells grow similarly until 28 hours from which time 
PIP4K2B-/- cells show delayed arrest at the G1/S checkpoint. At 28 hours 56% of WT 
DT40 cells are in G1 (95%CI 44% to 67%) compared to 43% of PIP4K2B-/- cells 
(95%CI 32% to 54%, P<0.05). At 32 hours 72% of WT DT40 cells are in G1 (95%CI 
59% to 85%) compared to 44% of PIP4K2B-/- cells (95%CI 33% to 56%, P<0.001). 
Bars show mean and 95% confidence interval. Data analysis by ANOVA. n=3 
biological replicates. 
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Figure 7 
Autophagy and mTORC1 activity in PIP4K2B-/- cells. 
A: Figure shows a representative western blot and quantification of three such blots 
by densitometry. Results normalised to WT DT40 cells in the absence of bafilomycin. 
In the absence of bafilomycin PIP4K2B-/- cells have a LC3-II to beta actin ratio of 
2.39 (95%CI 1.74 to 3.04, P<0.01, n=3 biological replicates). In the presence of 
bafilomycin PIP4K2B-/- cells maintain a higher LC3-II to beta actin ratio than WT 
DT40 cells (Mean 4.96, 95%CI 3.85 to 6.07 versus mean 2.39, 95%CI 1.74 to 3.04; 
P<0.001, n=3 biological replicates). Bars show mean and 95% confidence interval. 
Bafilomycin was used at 10nM and blocks flux through the autophagy pathway. Blots 
with Sigma AC74 anti-beta actin and Cell Signaling Technology #2775 anti-LC3B. 
B: mTORC1 mediated phosphorylation of p70 S6 kinase in PIP4K2B-/-, PIP4K2A-/-/- 
and WT DT40 cells. Figure shows a representative western blot and quantitation of 
three such blots by densitometry. Normalized to WT DT40 cells the phospho- to total 
p70 S6K ratio in PIP4K2B-/- cells is 0.49 (95%CI 0.31 to 0.66, P<0.001, n=3 
biological replicates) and in PIP4K2A-/-/- cells is 1.03 (95%CI 0.80 to 1.25, P=0.64, 
n=3 biological replicates). Bars show mean and 95% confidence interval. Blots with 
Cell Signaling Technology #9202 anti-p70 S6K and Cell Signaling Technology 
#9234 anti-phospho-Thr389-p70 S6K. 
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Supplementary Methods 
Constructs to endogenously tag PIP4K2A and PIP4K2B with EmGFP at the C-
terminus 
The constructs used to endogenously tag PIP4K2A and PIP4K2B with EmGFP at the 
C-terminus were built into the multiple cloning site of pBluescript SK+ (Stratagene). 
Constructs used for genomic targeting never need to be expressed off their plasmid 
vector and so pBluescript, a bacterial cloning vector, is suitable for this purpose. The 
general strategy for designing these constructs is described in the main methods 
section. 
 
The 2kb 5’ homology arm of the PIP4K2A tagging construct was PCR amplified from 
DT40 gDNA using primers 2A5FOR2 and 2A5REV2 and cloned into pBluescript 
SK+ between KpnI and XbaI sites. An unwanted BamHI site was removed from the 
5’ arm by site directed mutagenesis using primers SDM5 and SDM6. Next the coding 
sequence for EmGFP was PCR amplified from the plasmid EmGFP-C1 (primers 
EGFP_PCR_FOR_1 and EGFP_PCR_REV_1) and cloned into the construct between 
XbaI and BamHI sites. The 2kb 3’ homology arm of the targeting construct was then 
cloned into the construct between BamHI and NotI sites following PCR amplification 
from DT40 gDNA (primers 2A3FOR2 and 2A3REV2). Finally either a puromycin 
resistance cassette or a blasticidin resistance cassette was ligated into the BamHI site 
of the construct following excision from the pLOX PURO or pLOX BSR plasmids 
respectively. Having two constructs identical save for the antibiotic resistance 
conferred allowed sequential targeting of two PIP4K2A alleles using different 
selection antibiotics in order to derive the cell line PIP4K2Awt/EmGFP/EmGFP, which is 
resistant to both puromycin and blasticidin. Note that the antibiotic selection cassettes 
used contained their own eukaryotic promoters. Tagging two PIP4K2A alleles in 
DT40 cells leaves one wild type allele as DT40 cells exhibit trisomy for chromosome 
2, the chromosome on which the PIP4K2A gene is located. The correct integration of 
each targeting construct was tested by long-range PCR and sequencing, and the 
presence of a third PIP4K2A allele was verified by the ability to PCR out a wild type 
region spanning the terminal PIP4K2A exon from PIP4K2Awt/EmGFP/EmGFP gDNA. In 
order to verify the correct expression of the PtdIns5P 4-kinase alpha – EmGFP fusion 
protein PIP4K2Awt/EmGFP/EmGFP cells were subjected to immunoprecipitation and 
western blotting with anti-GFP antibodies. A GFP-containing protein of the correct 
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molecular weight was present in PIP4K2Awt/EmGFP/EmGFP cells but not in WT DT40 
cells. Importantly this 70KDa protein was the only GFP-containing species present in 
the tagged cells. These controls to ensure accurate construct integration and 
appropriate fusion protein expression were performed for every tagged cell line 
generated. 
 
In the case of PIP4K2B, we could start from the construct we previously generated to 
tag PI5P4Kβ with FLAG-(His)6 [15]. We excised the coding sequence for the FLAG-
(His)6 tag and ligated in the coding sequence for EmGFP. Once again two targeting 
constructs were made, identical save for the presence of either a puromycin or 
blasticidin resistance cassette. These constructs were used to sequentially target both 
alleles of PIP4K2B to render the cell line PIP4K2BEmGFP/EmGFP. 
 
Constructs to delete PIP4K2A and PIP4K2B 
The 5’ arm of the PIP4K2A deletion construct was amplified from DT40 gDNA using 
primers GGPIP4K2A_DEL_5’_FOR_2 and GGPIP4K2A_DEL_5’_REV_2 whilst the 
3’ arm was amplified using primers GGPIP4K2A_DEL_3’_FOR and 
GGPIP4K2A_DEL_3’_REV. These arms were ligated into pBluescript SK+ between 
KpnI and BamHI sites (5’ arm) and BamHI and NotI sites (3’ arm). A neomycin, 
puromycin, or blasticidin resistance cassette was then ligated into the BamHI site to 
generate three constructs that were used sequentially in order to delete all three 
PIP4K2A loci to generate PIP4K2A-/-/- cells. 
 
The primer pairs used to amplify the 5’ and 3’ arms of the PIP4K2B deletion 
construct were 2b_Ful_Del_PCR_5’_For_1 and 2b_Ful_Del_PCR_5’_Rev_1, and 
2b_Ful_Del_PCR_3’_For_1 and 2b_Ful_Del_PCR_3’_Rev_1 respectively. The two 
PIP4K2B loci in DT40 cells were sequentially deleted using puromycin and 
blasticidin resistance cassettes to derive the cell line PIP4K2B-/-. In order to generate a 
cell line expressing EmGFP-tagged PI5P4Kα in a PIP4K2B null background a 
neomycin resistance cassette was ligated into the PIP4K2A targeting construct already 
described. This construct was then be used to target a PIP4K2A locus in PIP4K2B-/- 
cells to generate the cell line PIP4K2AEmGFP/wt/wtPIP4K2B-/-. 
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Tagging of PIP4K2B at the C-terminus with the auxin degron system 
The coding sequence for osTIR1 (the part of the auxin degron system that needs to be 
stably expressed for the method to work) was PCR-amplified from the pNHK60 
plasmid (kindly provided by Gerard Evan, Cambridge) using the primers PCR-
osTIR1-F and R and subcloned into pcDNA3.1 between Ecor1 and Kpn1 restriction 
sites for stable transfection into DT40 cells. The DNA sequence encoding for an eight 
amino acid flexible linker followed by the AtIAA17 (degron) tag were PCR-amplified 
from the pNHK60 plasmid using the primers pBAIDII-1-F and R, and subcloned in 
frame with a C-terminal purification tag (a FLAG-(His6)2 tag) using a pBluescript 
SK+ derivative [15]. This construct was then excised between Sal1 and BamH1 
restriction sites and subcloned in between 5’ and 3’ PIP4K2B-targeting homology 
arms as described above. Antibiotic selection markers were then cloned in as 
described above. Sequential targeting of the PIP4K2B loci with constructs conferring 
resistance to different antibiotics yielded the cell line PIP4K2Bdegron/degron. Using a 
spare antibiotic selection cassette a PIP4K2A allele could then be targeted with an 
EmGFP tag as described above to give the cell line 
PIP4K2AEmGFP/wt/wtPIP4K2Bdegron/degron. 
 
Antibodies 
Target Manufacturer and Product Number 
6xHis tag Abcam Ab9108. 
Beta actin Sigma Aldrich. AC74. 
FLAG Sigma Aldrich A2220. 
Green fluorescent protein Invitrogen 33-2600 raised in mouse for 
western blotting 
Green fluorescent protein Invitrogen A-6455 raised in rabbit for 
immunoprecipitation 
Histone H3 Abcam ab1791. 
LC3B Cell Signaling Technology #2775. 
Mouse IgG (H+L) peroxidase conjugated Vector Laboratories PI-2000. 
Total p70 S6K Cell Signaling Technology #9202 
Phospho-Thr389-p70 S6K Cell Signaling Technology #9234 
PI5P4Kγ NeoMPS. Antibody raised in rabbit to a 
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peptide corresponding to amino acids 
333–352 of mouse PI5P4Kγ. See 
reference [17] in the main paper. 
Rabbit IgG (H+L) peroxidase conjugated Abcam ab16284. 
 
Primers 
Primer name Primer sequence (5’ to 3’) 
2A5FOR2 TTA AGG TAC CGA GCT GCT GAG TGA TCC 
TAA AG 
2A5REV2 GCA TTC TAG ACG TCA AGA TGT TGG CAA 
TAA AG 
SDM5 CAA GTA GGG ACA CAT TGC ATC CAA CTG 
CAG TAG TTC AG 
SDM6 CTG AAC TAC TGC AGT TGG ATG CAA TGT 
GTC CCT ACT TG 
EGFP_PCR_FOR_1 TCT TCA TCT AGA ATG GTG AGC AAG GGC 
GAG GAG 
EGFP_PCR_REV_1 CAC CAG GGA TCC TTA CTT GTA CAG CTC 
GTC CAT GC 
2A3FOR2 TAA TGG ATC CCC CCT CAT GTC ACA CCG 
GAC 
2A3REV2 TCA TGC GGC CGC TGC TAC ACA GAC AGA 
AAG TG 
GGPIP4K2A_DEL_5’_FOR_2 TGG TGG TAC CTA GTG GGA GGA CTT GCA 
AAT GAG G 
GGPIP4K2A_DEL_5’_REV_2 ACC AGG ATC CAA TCA GGT GTC AGA CCA 
CTT CAC G 
GGPIP4K2A_DEL_3’_FOR TAT AGG ATC CTC TGT GGG TAG TGT GCT 
TAG GTG 
GGPIP4K2A_DEL_3’_REV ATT AGC GGC CGC CTG CCA GTC TGT CCA 
TCC TCT GA 
2b_Ful_Del_PCR_5’_For_1 TCA AGG TAC CTG GAG AGC AGA TTG TCA 
CAC 
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2b_Ful_Del_PCR_5’_Rev_1 TGA CGG ATC CCA GAA AGA CAC ACA TAC 
ACA C 
2b_Ful_Del_PCR_3’_For_1 TGC AGG ATC CGC TTC CCT CGT GCT AAG 
GAT TG 
2b_Ful_Del_PCR_3’_Rev_1 TAA TGC GGC CGC GCT ACC TAC ATC CAG 
CAC AG 
PCR-osTIR1-F ATA TGA ATT CAT GAC GTA CTT CCC GGA 
GGA G 
PCR-osTIR1-R ATA TGG TAC CTT ACC ACT AGC AGC AGA 
ACC GGA G 
pBAIDII-1-F ATA TGT CGA CGG AGC TGG TGC AGG CG 
pBAIDII-1-R ATA TTC TAG AAG CTC TGC TCT TGC ACT T 
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Supplementary Results and Discussion 
It is important to establish that the various endogenous tags we have introduced into 
the PI5P4Ks do not in themselves affect protein expression or function. Unfortunately 
given the low expression of PI5P4Kα and PI5P4Kβ in DT40 cells, and the lack of 
isoform selective antibodies with which to investigate these enzymes, we cannot 
directly compare protein expression levels in tagged versus untagged cells. We can, 
however, investigate expression at the mRNA level by qPCR and find that the 
presence of endogenous EmGFP coding sequences does not affect this read-out of 
expression (supplementary figure 1A). We can also establish, by pulling down and 
blotting against the EmGFP tag, that the presence of the tag does not result in protein 
degradation; the only EmGFP-containing species detected in tagged cell lines is of the 
correct size for the full-length fusion protein (see supplementary figure 1B for an 
example in PIP4K2AEmGFP/EmGFP/wt cells). Most importantly, we can establish that 
phenotypic changes seen upon gene deletion do not occur in tagged cells, and 
therefore the tagged protein must be functioning normally at least as far as the 
phenotype studies is concerned. PIP4K2B null cells exhibit reduced p70 S6K 
phosphorylation at Thr389, but this phenotype is not observed in PIP4K2BEmGFP/EmGFP 
cells (supplementary figure 1C). The current manuscript is concerned principally with 
PI5P4Kβ, but we have data elsewhere that show the same principle to be true in cells 
where all three alleles of PI5P4Kα are tagged endogenously with EmGFP (Bulley, 
Droubi et al., in submission). In degron-tagged cell lines the question does not arise, 
as throughout this manuscript we have shown phenotypes to emerge only when the 
PI5P4K-degron fusion protein is removed with auxin addition. 
 
Supplementary Figure Legends 
Supplementary Figure 1 
A: In PIP4K2AEmGFP/EmGFP/wt cells the relative abundance of PIP4K2A mRNA 
compared to WT DT40 cells is 0.94 (95%CI 0.86 to 1.01) whilst the abundance of 
PIP4K2B mRNA is 0.91 (95%CI 0.84 to 0.97). In PIP4K2BEmGFP/EmGFP cells the 
relative abundance of PIP4K2B mRNA compared to WT DT40 cells is 1.01 (95%CI 
0.96 to 1.06) whilst the abundance of PIP4K2A mRNA is 1.10 (95%CI 1.02 to 1.17). 
Bars show mean and 95% CI. n=3 biological replicates in all cases. 
B: Immunoprecipitation and western blotting of EmGFP-containing species from WT 
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DT40 cells and PIP4K2AEmGFP/EmGFP/wt cells. Immunoprecipitation with Invitrogen A-
6455 anti-GFP and blot with Invitrogen 33-2600 anti-GFP. 
C: The phosphorylation status of p70 S6K at Thr389 in WT DT40, 
PIP4K2BEmGFP/EmGFP, and PIP4K2B-/- cells. Blots with Cell Signaling Technology 
#9202 anti-p70 S6K and Cell Signaling Technology #9234 anti-phospho-Thr389-p70 
S6K. Representative image from three replicates. 
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LC3-II as an assay of autophagy in DT40 WT and SJB020 Cells
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PIP4K2a and PIP4K2b Message in Tagged Cells Compared to Wild Type
DT40 by qPCR
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